Funding Opportunities
Intramural Funding
The UCLA Health Jonsson Comprehensive Cancer Center facilitates multiple intramural funding programs, including for seed grant, tumor specific projects, fellowships, and more. To administer these funding programs, we've established an online funding portal where you can learn about the different opportunities available to you, as well as download and submit applications
Called UCLA Bruin Learn, click the button below to access the portal. A one-time registration is required and you will need a UCLA Logon ID to use Bruin Learn. (If you do not already have a UCLA Logon ID, please visit this page to create one.)
Extramural Limited Submission Funding Opportunities
Below is a list of limited extramural funding opportunities that are provided as a courtesy to UCLA Health Jonsson Comprehensive Cancer Center members. For an opportunity to be included on this list, it must be a Limited Submission Opportunity (LSO) and applications are supported administratively by the Cancer Center's Grants Facilitation Team. Submission instructions are noted below. If you have any questions about a specific LSO listed below, please contact Sarah Anwar via email.
Listings are generally updated on a bimonthly basis. Entries are ordered by posting date, with most recent postings first. Opportunities are removed from this list once their final application due date has passed.
Posted April 15, 2024
V Foundation Pediatric V Scholar Cancer Research Grant
This Request for Applications (RFA) is specifically for pediatric cancer research through the V Scholar grant mechanism. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Emphasis for this grant mechanism is on supporting exceptional early career investigators at the Assistant Professor stage to be better positioned to leverage large R01 or similar sustaining grants.
This RFA is specifically for pediatric cancer research. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research. The grant specifies a three-year, $600,000 grant, paid in $200,000 annual installments. No indirect costs allowed.
How to apply
Each invited institution may submit one nominee to apply for this pediatric call. The sole nominee may apply in either the V Scholar or Translational (see listing below) program type. Both pediatric program RFAs are provided so you may decide which program best fits your nominee.
If you are interested in being considered for this LSO, please respond with a one-page research summary along with your biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].
Deadline
Research summary and biosketch due to the Cancer Center by Friday, April 19, 2024. If your project is selected by the Cancer Center, please be prepared to submit a full application by June 17, 2024.
V Foundation Pediatric Translational Cancer Research Grant
This Request for Applications (RFA) is specifically for pediatric cancer research through the Translational grant mechanism. Applicants may propose pediatric cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.
This RFA is specifically for pediatric cancer research that falls into preclinical/translational research as described above. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research. Grant specifies a four-year, $800,000 grant, paid in $200,000 annual installments.
How to apply
Each invited institution may submit one nominee to apply for this pediatric call. The sole nominee may apply in either the V Scholar (see listing above) or Translational program type. Both pediatric program RFAs are provided so you may decide which program best fits your nominee.
If you are interested in being considered for this LSO, please respond with a one-page research summary along with your biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].
Deadline
Research summary and biosketch due to the Cancer Center by Friday, April 19, 2024. If your project is selected by the Cancer Center, please be prepared to submit a full application by June 17, 2024.
Posted April 1, 2024
2025 Pew-Stewart Scholars Program for Cancer Research Award
The Pew-Stewart Scholars for Cancer Research supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer. The award provides $300,000 in flexible support—$75,000 per year for a four-year period. For the 2025 award, one nomination will be invited from each participating institution.
In line with The Alexander and Margaret Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research.
For more information, please visit their website.
How to apply
If you are interested in being considered for this LOS, please respond with a one-page research summary along with your biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].
Deadline
Research summary and biosketch due to the Cancer Center by Wednesday, April 17, 2024. If your project is selected by the Cancer Center, please be prepared to submit a full application by July 19, 2024.
Posted March 1, 2024
Breast Cancer Alliance Exceptional Project Grants
Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research and is open to applicants at institutions in the contiguous United States.
The grant provides salary support and project costs for a total of $100,000 (distributed over the one-year period as noted above.) Indirect costs, which are included in the $100,000 award, must be limited to 8 percent of total direct costs.
For more information, please email Sarah Anwar at [email protected] or Genevieve Ortega-Alves at [email protected]. You can also visit their website.
How to apply
If you are interested in being considered for this LOS, please respond with a one-page research summary along with your biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].
Deadline
Research summary and biosketch due to the Cancer Center by Monday, March 11, 2024. If your project is selected by the Cancer Center, please be prepared to submit a full application by July 19, 2024.
Breast Cancer Alliance Young Investigator Grants
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions in the contiguous United States. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.
The term of the Young Investigator Grant is two years, beginning on March 1, 2025. The grant provides salary support and project costs for a total of $125,000 (distributed over the two-year period as noted above.) Indirect costs, which are included in the $125,000 award, must be limited to 8 percent of total direct costs.
For more information, please email Sarah Anwar at [email protected] or Genevieve Ortega-Alves at [email protected]. You can also visit their website.
How to apply
If you are interested in being considered for this LSO, please respond with a one-page research summary along with your biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].
Deadline
Research summary and biosketch due to the Cancer Center by Monday, March 11, 2024. If your project is selected by the Cancer Center, please be prepared to submit a full application by July 19, 2024.
V Foundation Adult Translational Cancer Research
Adult Translational Cancer Research 2024 Request for Applications PURPOSE OF AWARD: This Request for Applications (RFA) is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Applicants may propose adult cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial. SPECIAL FOCUS AREA:
The grant specifies a four-year, $800,000 grant, paid in annual installments. Indirect costs up to 10 percent of direct costs allowed.
For more information, please email Sarah Anwar at [email protected] or Genevieve Ortega-Alves at [email protected].
How to apply
If you are interested in being considered for this LSO, please respond with a one-page research summary along with your biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].
Deadline
Research summary and biosketch due to the Cancer Center by Monday, March 11, 2024. If your project is selected by the Cancer Center, please be prepared to submit a full application by April 19, 2024.